11 results

Research & Innovation

Posted on 01.07.2022

Putting medical technologies at the heart of health innovation in Europe

From robotic surgery and wearables to connected devices and AI-powered diagnostics, medical technologies are reinventing healthcare. Europe’s medtech sector is making unprecedented investments in research & innovation – and joining the Innovative Healthcare Initiative for the first time. I sense that something big is happening in healthcare research. A tectonic shift in Europe’s health innovation […]

By Patrick Boisseau Director Research and Innovation, MedTech Europe

shutterstock_2029745357
Cardio

Posted on 04.11.2021

Heart failure – the time to act is now

With Europe’s ageing population comes several social, economic and environmental benefits. It also brings rising risks of cardiovascular disease (CVD) which must be managed to protect citizens’ wellbeing and the sustainability of our health systems. That is why we are inspired to see 15 European and international health organisations joining forces to form the European […]

By Markus Schwertfeger Senior Global Medical Affairs Lead Roche Diagnostics International

shutterstock_1766372960
Digital

Posted on 28.01.2021

Answering the Call of Telehealth

Even before the COVID-19 pandemic, video consultations were on the rise, with many healthcare systems advocating a digital-first approach. In patient care and clinical trials, demand for virtual care has never been higher. The pandemic has accelerated this shift. For me, it has been exciting to collaborate with health systems at a time of urgent […]

By Sorin Stircu Regional MedTech Strategist at E*HealthLine - Europe Global Office

slider-website-April-2020-VODI-HF
Access

Posted on 29.04.2020

Maximising the potential of diagnostic information in heart failure care

Covid-19 has proven a seismic event for our societies, and it is easy to forget that the pandemic will not dominate the debate on healthcare forever. Yet by any rational measure, efforts to manage long-term conditions will continue to be responsible for the majority of healthcare costs into the future. Heart failure (HF) is, and […]

By Ed Harding Network Director, Heart Failure Policy Network - Co-founder and Managing Director of The Health Policy Partnership

shutterstock_1238405779
Digital

Posted on 06.01.2020

Digital biomarkers are the future of precision medicine

Many are probably already familiar with “Biomarkers”. This is a term usually used to describe a molecule or gene that indicates a change in a person’s health or risk of disease. As technology take’s its innovative course in healthcare, Biomarkers are going digital.   Digital tools, such as smartphones, wearables and fitness trackers, continually collect health […]

By Sorin Stircu Regional MedTech Strategist at E*HealthLine - Europe Global Office

Fotolia_164138527_Subscription_Monthly_M
Cancer

Posted on 05.06.2018

Can screening decrease lung cancer mortality rates?

This blog is part of the Early Diagnosis campaign #BeFirst Early diagnosis and care can prevent illness from developing and slow disease progression. Lab tests, genetic tests, tests for chronic diseases and modern lab diagnostics can help facilitate earlier intervention and improves outcomes for patients and are increasingly valuable in informing treatment choice.  Read the other […]

By Jo Van den Broeck Marketing Director EMEA - Disease State Management - Lung Health - Medtronic

Fotolia_112169466_Subscription_Monthly_M
Digital

Posted on 29.11.2016

Health in the information age

eHealth technologies are pulling together personal information from diverse sources to ensure a more personalised, informed healthcare service – it’s what patients expect Precision medicine is the use of all available information about a patient to produce the most informed care plan possible. This is often associated with using genetic or other “-omics” information to […]

By Colin Henderson VP EMEA Strategy, Solutions & Partners and GM Emerging Markets - Orion Health

superbugs-physicianview_1
Value

Posted on 29.07.2014

Superbugs: “The physician community needs to get its act together”

The WHO has been raising the ‘threat level’ on this issue progressively each year for the last decade, with individual disease reports highlighting the emerging threat of antimicrobial resistance (AMR). This year’s report however highlights this pandemic like never before, demonstrating it’s global nature and its profound impact on health and economics. I’m a cardiologist and the report speaks to me – actually it screams out loud: “We need to get our act together”.

By Sameer Bansilal Attending Physician in the Mount Sinai Cardiovascular Institute

testtubes
Value

Posted on 28.08.2013

How One Diagnostic Test Can Save Billions of Euros Per Year

In the past, percussion of the abdomen, taking temperature, or tasting sugar in urine were considered diagnostic standard of care methodologies. Today, invitro diagnostics (IVD) provide additional objective biomarkers that diagnose cancer, infections, heart attacks and many other health conditions.

By Manfred Scholz Manfred Scholz, PhD, MBA, Founder, President and Principal Consultant